Tirzepatide (GLP-1/GIP) Tirzepatide is a first-in-class dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist, providing synergistic metabolic effects for diabetes and obesity research
Image source:ResearchGate The basic biochemistry of NAD with glutathione explains why these molecules work so well together for cell support
Some practitioners describe using it alongside a BPC-157/TB-500 stack during the later phases of healing when acute repair transitions to tissue remodeling and strengthening
[DOI] [PMC free article] [PubMed] [Google Scholar] Lavoie H, Gagnon J, Therrien M
Many patients come in asking for a specific treatment, but after meeting with the doctor, they realize what their body actually needs and thats where real results begin
Additionally, patients should be observed for signs and symptoms of megaloblastic anemia, such as fatigue, pallor, and anorexia